Vancomycin-resistant enterococci colonization and bacteremia in patients with hematological malignancies

Journal of Infection in Developing Countries

Volumn 8, Issue 9, 2014, Pages 1113-1118

  Gedik, Habip ^a   Yıldırmak, Taner ^a   Şimşek, Funda ^a   Kantürk, Arzu ^a   Arıca, Deniz ^a   Aydın, Demet ^a   Yokuş, Osman ^a   Demirel, Naciye ^a   Arabaci, Çiğdem ^a  

^a OKMEYDANI TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Bacteremia; Colonization; Hematological patients; Vancomycin resistant enterococci

Indexed keywords

GENTAMICIN; LINEZOLID; SULTAMICILLIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTERIAL GAS; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIUM IDENTIFICATION; BLOOD CULTURE; BLOODSTREAM INFECTION; BONE MARROW BIOPSY; DYSPNEA; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FEBRILE NEUTROPENIA; FEMALE; HAIRY CELL LEUKEMIA; HEMATOLOGIC MALIGNANCY; HUMAN; INFECTION RATE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; NONHUMAN; OBSERVATIONAL STUDY; PNEUMONIA; RETROSPECTIVE STUDY; SYSTEMIC MYCOSIS; URINARY TRACT INFECTION; URINE CULTURE; VANCOMYCIN RESISTANT ENTEROCOCCUS; COMPLICATION; GRAM-POSITIVE BACTERIAL INFECTIONS; HEMATOLOGIC DISEASE; INCIDENCE; INFECTION CONTROL; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PROCEDURES; TURKEY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HEMATOLOGIC NEOPLASMS; HUMANS; INCIDENCE; INFECTION CONTROL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TURKEY; VANCOMYCIN-RESISTANT ENTEROCOCCI; YOUNG ADULT;

EID: 84907010392     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.4451     Document Type: Article

References (19)

1. Murray BE, Barlett JG (2004) Enterococci. In Gorbach SL, Barltett JG, Blacklow NR, editors. Infectious Diseases, 3rd edition. Philadelphia: Lippincott Williams & Wilkins. 1610-1615.
2. Moellering RC (2005) Enterococcus species, Streptococcus bovis, and Leuconostoc species. In Mandell GL, Bennett JE, Dolin R, editors. Principles and Practices of Infectious Diseases, 6th edition. Philadelphia: Elsevier Churchill Livingstone. 2411-2417.
3. Safdar N, Maki DG (2002) The commonality of risk factors for nosocomial colonization and infection with antimicrobial resistant Staphylococcus aureus, Enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 136: 834-844.
4. Austin DJ, Bonten MJ, Weinstein RA, Slaughter S, Anderson RM (1999) Vancomycin-resistant enterococci in intensive-care hospital setting: Transmission dynamics, persistence, and the impact of infection control programs. Proc Natl Acad Sci U S A 96: 6908-6913.
5. Mikulska M, Del Bono V, Prinapori R, Boni L, Raiola AM, Gualandi F, Van Lint MT, Dominietto A, Lamparelli T, Cappellano P, Bacigalupo A, Viscoli C (2010) Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis 12: 505-512.
6. Kuehnert MJ, Jernigan JA, Pullen AL, Rimland D, Jarvis WR (1999) Association between mucositis severity and vancomycin-resistant enterococcal bloodstream infection in hospitalized patients. Inf Cont and Hosp Epidemiol 20: 660-663.
7. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR; Infectious Diseases Society of America (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52: 56-93.
8. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, Feld R, Pizzo PA, Rolston KV, Shenep JL, Young LS (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34: 730-751.
9. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE; European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46: 1813-1821.
10. Hospital Infection Control Practices Advisory Committee (HICPAC) (1995) Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 16: 105-113.
11. Harbarth S, Cosgrove S, Carmeli Y (2002) Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrob Agents Chemother 46: 1619-1628.
12. Vergis EN, Hayden MK, Chow JW, Snydman DR, Zervos MJ, Linden PK, Wagener MM, Schmitt B, Muder RR (2001) Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia: a prospective multicenter study. Ann Intern Med 135: 484-492.
13. Furtado GH, Mendes RE, Pignatari AC, Wey SB, Medeiros EA (2006) Risk factors for vancomycin-resistant Enterococcus faecalis bacteremia in hospitalized patients: an analysis of two case-control studies. Am J Infect Control 34: 447-451.
14. Blijlevens NM (2005) Implications of treatment-induced mucosal barrier injury. Curr Opin Oncol 17: 605-610.
15. Roghmann MC, McCarter RJ Jr, Brewrink J, Cross AS, Morris JG Jr (1997) Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia. Clin Infect Dis 25: 1056-1059.
16. Weinstock DM, Conlon M, Iovino C, Aubrey T, Gudiol C, Riedel E, Young JW, Kiehn TE, Zuccotti G (2007) Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant 13: 615-621.
17. Olivier CN, Blake RK, Steed LL, Salgado CD (2008) Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE. Infect Control Hosp Epidemiol 29: 404-409.
18. Salgado CD, Farr BM (2003) Outcomes associated with vancomycin resistant enterococci: a meta- analysis. Infect Control Hosp Epidemiol 24: 690-698.
19. DiazGranados CA, Zimmer SM, Klein M, Jernigan JA (2005) Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream. Clin Infect Dis 41: 327-333.